1 |
Kabra N, Li Z, Chen, L, et al (2009). SirT1 is an inhibitor of proliferation and tumor formation in colon cancer. J Biol Chem, 284, 18210-7.
DOI
|
2 |
Karin M, Yamamoto Y, Wang QM (2004). The IKK NF-kappa B system: a treasure trove for drug development. Nat Rev Drug Discov, 3, 17-26.
DOI
ScienceOn
|
3 |
Lee JH, Song MY, Song EK, et al (2009). Overexpression of SIRT1 protects pancreatic beta-cells against cytokine toxicity by suppressing the nuclear factor-kappaB signaling pathway. Diabetes, 58, 344-51.
DOI
|
4 |
Lennon FE, Mirzapoiazova T, Mambetsariev B, et al (2014). The Mu opioid receptor promotes opioid and growth factorinduced proliferation, migration and Epithelial Mesenchymal Transition (EMT) in human lung cancer. PloS one, 9, 91577.
DOI
|
5 |
Lennon FE, Moss J, Singleton PA (2012). The mu-opioid receptor in cancer progression: is there a direct effect? Anesthesiology, 116, 940-5.
DOI
|
6 |
Lv L, Shen Z, Zhang J, et al (2014). Clinicopathological significance of SIRT1 expression in colorectal adenocarcinoma. Med Oncol, 31, 965.
DOI
|
7 |
Nuckols TK, Anderson L, Popescu I, et al (2014). Opioid prescribing: a systematic review and critical appraisal of guidelines for chronic pain. Ann Intern Med, 160, 38-47.
|
8 |
Qin Y, Li L, Chen J, et al (2012). Fentanyl inhibits progression of human gastric cancer MGC-803 cells by NF-kappaB downregulation and PTEN upregulation in vitro. Oncol Res, 20, 61-9.
DOI
|
9 |
Aggarwal BB (2004). Nuclear factor-kappaB: the enemy within. Cancer Cell, 6, 203-8.
DOI
ScienceOn
|
10 |
Xu TP, Shen H, Liu LX, Shu YQ (2013). Plumbagin from Plumbago Zeylanica L induces apoptosis in human nonsmall cell lung cancer cell lines through NF- inactivation. Asian Pac J Cancer Prev, 14, 2325-31
DOI
ScienceOn
|
11 |
Yeung F, Hoberg JE, Ramsey CS, et al (2004). Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J, 23, 2369-80.
DOI
ScienceOn
|
12 |
Yi J, Luo J (2010). SIRT1 and p53, effect on cancer, senescence and beyond. Biochim Biophys Acta, 1804, 1684-9.
DOI
|
13 |
Ford J, Jiang M, Milner J (2005). Cancer-specific functions of SIRT1 enable human epithelial cancer cell growth and survival. Cancer Res, 65, 10457-63.
DOI
ScienceOn
|
14 |
Bovill JG. (2010). Surgery for cancer: does anesthesia matter? Anesth Analg, 110, 1524-6.
DOI
|
15 |
Chen LF, Greene WC (2004). Shaping the nuclear action of NF-kappaB. Nat Rev Mol Cell Biol, 5, 392-401.
DOI
|
16 |
Domingo-Domenech J, Oliva C, Rovira A, et al (2006). Interleukin 6, a nuclear factor-kappaB target, predicts resistance to docetaxel in hormone-independent prostate cancer and nuclear factor-kappaB inhibition by PS-1145 enhances docetaxel antitumor activity. Clin Cancer Res, 12, 5578-86.
DOI
ScienceOn
|
17 |
Gang D, Hongwei H, Hedai L, et al (2013). The tumor suppressor protein menin inhibits NF-kappaB-mediated transactivation through recruitment of Sirt1 in hepatocellular carcinoma. Mol Biol Rep, 40, 2461-6.
DOI
|
18 |
Ghosh S, May MJ, Kopp EB (1998). NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol, 16, 225-60.
DOI
ScienceOn
|
19 |
Huffman DM, Grizzle WE, Bamman MM, et al (2007). SIRT1 is significantly elevated in mouse and human prostate cancer. Cancer Res, 67, 6612-8.
DOI
ScienceOn
|
20 |
Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.
DOI
|
21 |
Jung W, Hong KD, Jung W Y, et al (2013). SIRT1 Expression Is Associated with Good Prognosis in Colorectal Cancer. Korean J Pathol, 47, 332-9.
DOI
|